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President’s Message

Value is based on the
patient experience
By David Tilstra, MD
President, CentraCare Clinic
I recently heard two speakers talk about health care reform.
Each had very different perspectives on the federal approach to
health care reform known as Obamacare or Affordable Care Act.
Interestingly, both believed that health care reform was needed, and
each was convinced if their version didn’t move forward, the country
likely would see major turmoil in the coming years.
While their versions differed, what was clear is that delivery of health
care will need to change from the traditional method of fee per service
to a “value approach.” Understanding what value is and delivering on it
will be necessary regardless of the rhetoric coming out of Washington.
What is value? First, patients perceive value as the interaction and
service they get from their health care provider. To many patients, quality
is defined by their patient experience. If we don’t deliver on the experience,
there is no value to the patients. Second, rapid communication of clinical
patient information is critical for improving the overall quality of care.
While most providers do react appropriately if they have all the
information, we all have experienced the frustration of trying to manage
a patient while not knowing what a specialist prescribed the day before
or the MRI result completed in another institution a few days ago.
That information needs to be available instantaneously, just like credit
card purchases that show up online a few minutes after we purchase
something. We, as a profession, need to have the attitude that our work
isn’t done until we appropriately communicate what we did during
a patient visit. Third, we need to understand what clinical activities
provide value and what is unnecessary or frankly, unhelpful.
continued on page 2

Seasonal flu and
our role as health
care providers
By George Morris, MD,
Medical Director,
CentraCare Clinic
Influenza (flu) is poised and ready to reemerge to affect
our patients and us. We know there are only a few things
we can do to decrease the spread. Good hand hygiene and
immunization are two of the most effective measures.
The Centers for Disease Control and Prevention (CDC)
estimates that 5 to 20 percent of Americans come down
with the flu during each flu season. Children are two to three
times more likely than adults to get sick with the flu, and
children frequently spread the virus to others. Although
most people recover from the illness, the CDC estimates
that in the United States more than 200,000 people are
hospitalized and about 36,000 people die from the flu
and its complications every year.
We know that flu can be passed even before a person knows
they are sick, and most people are sick for at least a week.
To avoid spreading the flu, the CDC recommends that ill
people stay home for at least 24 hours after a fever is gone.
We encourage all of our providers and staff to receive the
influenza immunization each season. Most companies now
produce quadrivalent vaccines to improve coverage of
multiple strains. Last year’s vaccine effectiveness was about
56 percent when measured as a percentage of individuals
who saw a provider within seven days of becoming ill.
We realize this is not a great success rate, but immunization
has shown effectiveness in decreasing time lost from work,
hospitalizations, serious illness and death. One study showed
one life saved per 4,000 immunizations. CentraCare Health’s
goal is to obtain close to 100 percent immunization rate of
our providers and staff. We cannot completely prevent our
patients from becoming ill, but vaccination is one thing
we can do to protect our patients and us.

If not for YOU,
get the flu vaccine for THEM.

Rheumatology update
Our Rheumatology department has temporarily
closed its practice to any new consultations or new
visits until further notice. This is because three of
our five rheumatologists have departed for essentially
unrelated reasons in the past six months.
Rheumatologists Aaron Holmgren, MD, and
Bharath Akkara Veetil, MBBS, are committed to
the challenging task of managing our established
patients, many who are taking immuno-modulating
drugs requiring rheumatologic management.
This closure will impact patients who have been
seen in the past, but have not required active
follow-up. Similarly, we are unable to
accommodate new patients who have been seen at
St. Cloud Hospital, even if seen by rheumatology
within the hospital. These patients will be asked to
follow-up with their primary care provider.
We understand and apologize for the burden this
restriction places on our local and regional medical
communities, especially given the relative scarcity
of rheumatology services. Please know we are fully
engaged in an effort to recruit new providers to our
practice and to extend our services by other means.
In the interim, rheumatology services are available
in Brainerd, Maple Grove, the Twin Cities, Duluth,
Fargo, N.D. and Sioux Falls, S.D. Our staff can help
answer questions that you or your patients may have.
It is our sincere hope to reopen our practice as soon
as possible so we again can provide new patient
consultations in the St. Cloud area. Until that time,
we thank you for your understanding and support.
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It’s more than just cutting back on what we do or
looking for the cheapest drugs, tests or materials.
If cutting back on regular HgbA1cs results in a
hospitalization for uncontrolled diabetes, we
haven’t saved any money. We need to continue
to evaluate what we do to better understand what
provides value to the patient.
This list can go on, and I am sure many of you could
name more ways to provide value to the patient.
As a profession that is under pressure to change
our mode of health care delivery, we need to focus
now more than ever on putting the patient first.

Transvenous interventional neurological techniques
By Adnan Qureshi, MBBS, interventional neurologist, CentraCare Clinic
While all of us are aware of the transluminal intervention
within the arterial system, the potential and spectrum of
transvenous interventional neurological techniques is less
well understood. Transvenous interventional procedures are
performed via catheters that are introduced through the
femoral vein and advanced through the iliac vein, inferior
vena cava, right atrium, superior vena cava, brachiocephalic
vein and subsequently the internal jugular vein. Microcatheters,
angioplasty balloons, and stents can be further introduced
into the cerebral dural venous sinuses including sigmoid,
transverse, superior sagittal, and other sinuses. Several
procedures can be performed as outlined below:
1. Evaluation of pituitary tumors and Cushing’s disease:
Venous blood sampling via catheterization of petrosal
veins bilaterally can allow measurement of various
hormones secreted by both lobes of pituitary glands
at baseline and after injection of dexamethasone. The
functional activity assessment allows determination of
concentration and laterality of hormone secretions.
The test is the gold-standard method for diagnosing
Cushing’s disease.

4. Treatment of intracerebral hemorrhage:
Increase in venous pressure due to
thrombosis of the cerebral veins or sinuses
can result in intracerebral hemorrhages.
Lysis of thrombus using transvenous
thrombolytics or mechanical thrombectomy
can prevent further intraparenchymal hemorrhages
and intracranial hypertension. Intracerebral hemorrhage
also can occur because of increase in venous pressure
secondary to arteriovenous fistulas derived from external
or internal carotid artery branches pathologically
anastomosing with sigmoid or transverse sinuses.
Obliteration of these abnormal channels through coils
or liquid embolic agents can result in further progression
of symptoms or new intracerebral hemorrhages.

5. Treatment of multiple sclerosis: Recent studies have
documented that venous engorgement and perivenular
inflammation can be seen in patients with multiple
sclerosis. Impairment of venous outflow due to stenosis
or occlusion of transverse or sigmoid sinuses can be seen
in these patients.
Most patients with
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to diagnose seizures: This technique is in early phase of
3. Treatment of tinnitus: Tinnitus can be secondary to
evolution. Microwires placed in transverse or straight
enlargement of veins that connect sigmoid sinus to
sinus can conduct electrical impulses from brain tissue
external jugular veins. These veins are located behind
located in the vicinity of the sinuses. Such areas are
the ear and increased flow creates refractory tinnitus
not assessed appropriately by surface electrodes and
(see Figure 2 on next page). The external carotid artery
transvenous approach may provide an alternate method
branches can anastomose with sigmoid or transverse
for electroencephalographic monitoring.
sinuses creating refractory tinnitus through flow via
these anastomic channels. Obliteration of these
continued on next page
abnormal channels through coils or liquid embolic
agents can result in complete cure of symptoms.

7. Treatment of pediatric
venous malformations:
Dilation and ectasias of
cerebral venous sinuses
can occur in conditions
such as Vein of Galen
malformation and result
in hydrocephalus,
cephalomegaly, and
congestive heart failure.
Early recognition and
treatment by transvenous
obliteration of malformation
can be life-saving and
prevent long-term disability.
Figure 2: A lateral venogram
demonstrates an abnormally dilated
vein behind the ear connecting sigmoid
sinus to external jugular vein (arrows)
in a patient with tinnitus.

The applications of
transvenous approach and
treatment success rates are
increasing with new technology.
As medical professionals, we

must be aware of the indications of transvenous approaches
so we can provide the best options for our patients.
We recently saw a 21-year-old female with a three-year
history of idiopathic intracranial hypertension whose
headaches have been refractory to medical therapy.
Previous vision loss responded to lumbar puncture.
In an 18-month period, she had 19 lumbar punctures with
opening pressures as high as 65 cm H20. We performed
cerebral angiography and venography and she was noted to
have severe left transverse-sigmoid venous sinus stenosis.
Pressure measurements were obtained within the transverse
sinus and subsequently in the sigmoid sinus and a gradient
of 12 mm Hg was demonstrated. At that point, primary
angioplasty was performed with excellent venographic
results. The previously demonstrated pressure gradient
also normalized. The patient’s headache resolved at
24 hours and her vision was back to normal.
For more information or a referral to CentraCare Clinic’s
Interventional Neurologists, call 320-240-2829.

Should E-cigarettes be used to help smokers quit?
By Nabeel Ailabouni, DO, Family Medicine, CentraCare Clinic – Big Lake
Since the recent cigarette cost increase, a common topic
for patients has been the role of e-cigarettes in smoking
cessation. The electronic cigarette, or e-cigarette, is a
simple, battery-operated device that heats up liquid nicotine
to create a vapor that a person inhales and then exhales.
This mimics the action of smoking and nicotine is delivered
to the user’s lungs and into the blood stream. E-cigarettes
were first developed in China in the early 2000s and have
been in the United States since about 2007. Many see
e-cigarette use as a “healthier” alternative to cigarettes since
there is no smoke and just nicotine vapor. But is this true?
There are several concerning issues with e-cigarette use.
The FDA is trying to ban e-cigarettes for use until adequate
research can be conducted to assess safety. Granted,
the main chemicals in the devices — nicotine, glycol
(which makes the smoke appearance) and flavoring —
have minimal to no health effects when compared to
cigarettes, but without adequate testing the facts remain
unknown. Also, lack of federal or legal regulations on
product manufacturing creates concern about what
additives may be included in the device without consumer
knowledge, as well as what health effects could arise.
The most recent FDA investigation did show traces of
carcinogenic (cancer-causing) chemicals in the e-cigarette,
but the level was nowhere near the amount of cancer-causing
chemicals in cigarettes. The FDA is pushing for more
research on these devices before suggesting use due
to the lack of evidence to support safe usage.

The other major issue with the e-cigarette
is more on a social level and has to deal with
the fact that e-cigarettes contain no tobacco.
One might say that no tobacco is a good thing,
but this means that e-cigarettes are not subject
to tobacco laws so a minor can purchase the product without
an ID. Although nicotine may not have “adverse” health risks,
it is a very highly addictive drug minors can obtain easily.
While most consumers may be unaware about the lack of
safety evidence, Canada, Australia, Mexico and Israel have
banned e-cigarettes from sale or usage. Also, Hennepin
County recently banned e-cigarette use on any Hennepin
County-owned property. In addition, Metro Transit also is
in the process of banning these products on trains and buses
until further research is conducted to assess not only its
safety to the user, but also with second-hand exposure.
From a medical standpoint, it is very difficult for providers to
make an informed judgment on the safety of this product due
to the lack of evidence. With that said, it seems reasonable that
use of these products for smoking cessation may be beneficial,
but it also must be understood they have not been studied to
even show any effectiveness in smoking cessation.
In my opinion, there are other proven and safe alternatives to
smoking cessation, such as the FDA-approved nicotrol inhaler,
and until further evidence is available, providers should not
recommend e-cigarette use as an alternative to smoking.

Introducing our new CentraCare Clinic Specialists
Cardiology

CentraCare Heart & Vascular Center at Willmar, 320-656-7020

Anthony Annese, MD
Medical School: Boston University
Residency: Boston University Medical School
Fellowship: Cardiovascular Disease, Cleveland Clinic, Weston, Florida
Certification: Cardiac CT, Johns Hopkins University, Baltimore, MD
Board Certified: Echocardiography and Nuclear Cardiology
Clinical Interests: Heart Failure

General Surgery

CentraCare Clinic – River Campus, 320-252-3342

Andrea Kales, MD
Medical School: Creighton University, Omaha, Neb.
Residency: TriHealth and Affiliate Hospitals, Cincinnati, Ohio
Board Eligible: General Surgery
Clinical Interests: Breast cancer, thyroid and laparoscopic surgery

Maternal & Fetal Medicine

St. Cloud Hospital, 320-656-7024

Jessica Swartout, MD
Medical School: University of Minnesota, Minneapolis
Residency: University of Texas Southwestern/Parkland Memorial Hospital, Dallas
Fellowship: University of Minnesota, Minneapolis
Board Certified: Maternal & Fetal Medicine and Obstetrics/Gynecology

Neonatal-Perinatal Medicine

St. Cloud Hospital, 320-255-5781

Timothy Vedder, MD
Medical School: University of Minnesota, Minneapolis
Residency: Tripler Army Medical Center, Honolulu, Hawaii
Fellowship: Tripler Army Medical Center, Honolulu, Hawaii
Board Certified: Neonatal-Perinatal Medicine and Pediatrics

Pediatrics

CentraCare Clinic – Women & Children, 320-654-3610

Andrew Maloney, MD
Medical School: University of Nebraska, Omaha
Residency: Creighton-Nebraska-Children’s Health Foundation Joint Pediatric Program, Omaha
Board Eligible: Pediatrics
Clinical Interests: Asthma and Sports Medicine
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Documentation is the key for appropriate reimbursement
By Connie Goulet, CPC; Sue Stein, CPC; and Jessica Timmer, CPC, Compliance Specialists,
CentraCare Clinic
Assigning codes based on underlying conditions is not a new
concept of ICD-10, but providers need to better understand
how their documentation of the patients’ illnesses affects
coding. Through education of the coding staff and the
medical staff, we can improve documentation practices by:
• clearly stating manifestations of chronic conditions;
• differentiating between specific conditions
(i.e. Diabetes Mellitus Type I and Diabetes Mellitus
Type II. If the latter condition requires insulin, it should
be noted as Diabetes Mellitus, Type II, insulin requiring)
(as opposed to insulin dependent);
• showing any existing relationships between hypertensive
disease, congestive heart failure and renal failure;
• fully documenting exacerbations of COPD;
• identifying the vessel affected as either native or grafted,
autologous or non-autologous, and/or vein or artery
graft material used, when a diagnosis of coronary
atherosclerosis is made;
• indicating the side affected — dominant or
non-dominant — when hemiplegia occurs following
a stroke;
• clearly distinguishing between traumatic and
pathological fractures when diagnosing fractures,

along with laterality and visit encounter (i.e. initial,
subsequent or sequel) in addition to if routine healing,
delayed healing, non-union or malunion or open/closed;
and
• clearly documenting complications of medical
and surgical care.
Consider these two patients. Patient A is a type 2 diabetic
with well-controlled diabetes. Patient B is a type 2 diabetic
with uncontrolled diabetes who also suffers from diabetesrelated chronic kidney disease.
If the provider documents “diabetes mellitus” for both
patients, coders would report the same code, even though
the patients have very different conditions. The provider
loses reimbursement on Patient B, who is sicker and
requires more care.
In today’s busy health care environment, it is important
to remember that submitted codes will affect future payment
schedules, research databases and public reporting of disease
incidence to name a few. It is very important to document
to the highest specificity of known condition or disease.

